Expression of p-Lyn and p-Btk in various primary BM cells (MNC) as determined by Western blotting
| No. . | Diagnosis . | KIT D816V . | Lyn . | p-LynTyr507 . | p-SrcTyr416 . | Btk . | p-BtkTyr223 . |
|---|---|---|---|---|---|---|---|
| 10 | ISM | + | ± | − | − | + | − |
| 11 | ISM | + | ± | − | − | + | − |
| 12 | ISM | − | − | − | − | ± | − |
| 13 | ISM | + | + | − | nt | + | − |
| 16 | ISM | + | + | − | nt | + | − |
| 25 | SSM | + | + | + | nt | nt | nt |
| 31 | ASM/MDS | − | + | + | + | + | + |
| 32 | ASM/CMML | + | + | + | + | + | + |
| 33 | ASM/CMML | + | + | + | + | + | + |
| 36 | MCL | − | nt | nt | nt | + | + |
| AML 1 | AML | − | + | − | nt | + | − |
| AML 2 | AML | − | + | ± | nt | + | − |
| AML 3 | AML | − | + | + | nt | + | − |
| AML 4 | AML | − | + | + | nt | + | − |
| AML 5 | AML | − | + | + | nt | + | − |
| CML 1 | CML | − | + | − | nt | + | − |
| CML 2 | CML | − | + | + | nt | + | − |
| CML 3 | CML | − | + | ± | nt | + | − |
| CML 4 | CML | − | + | ± | nt | + | − |
| CML 5 | CML | − | + | − | nt | + | − |
| CNL | CNL | − | + | ± | nt | + | − |
| NBM 1 | NBM | − | + | − | nt | + | − |
| NBM 2 | NBM | − | + | − | nt | + | − |
| NBM 3 | NBM | − | + | − | nt | + | − |
| No. . | Diagnosis . | KIT D816V . | Lyn . | p-LynTyr507 . | p-SrcTyr416 . | Btk . | p-BtkTyr223 . |
|---|---|---|---|---|---|---|---|
| 10 | ISM | + | ± | − | − | + | − |
| 11 | ISM | + | ± | − | − | + | − |
| 12 | ISM | − | − | − | − | ± | − |
| 13 | ISM | + | + | − | nt | + | − |
| 16 | ISM | + | + | − | nt | + | − |
| 25 | SSM | + | + | + | nt | nt | nt |
| 31 | ASM/MDS | − | + | + | + | + | + |
| 32 | ASM/CMML | + | + | + | + | + | + |
| 33 | ASM/CMML | + | + | + | + | + | + |
| 36 | MCL | − | nt | nt | nt | + | + |
| AML 1 | AML | − | + | − | nt | + | − |
| AML 2 | AML | − | + | ± | nt | + | − |
| AML 3 | AML | − | + | + | nt | + | − |
| AML 4 | AML | − | + | + | nt | + | − |
| AML 5 | AML | − | + | + | nt | + | − |
| CML 1 | CML | − | + | − | nt | + | − |
| CML 2 | CML | − | + | + | nt | + | − |
| CML 3 | CML | − | + | ± | nt | + | − |
| CML 4 | CML | − | + | ± | nt | + | − |
| CML 5 | CML | − | + | − | nt | + | − |
| CNL | CNL | − | + | ± | nt | + | − |
| NBM 1 | NBM | − | + | − | nt | + | − |
| NBM 2 | NBM | − | + | − | nt | + | − |
| NBM 3 | NBM | − | + | − | nt | + | − |
Expression of total Lyn, p-Lyn, total Btk, and p-Btk was assessed by Western blotting as described in “Western blot experiments.” Score: + indicates positive;±, weak band; and −, negative.
MNC indicates mononuclear cell; SM, systemic mastocytosis; ISM, indolent SM; SSM, smouldering SM; ASM, aggressive SM; MDS, myelodysplastic syndrome; CMML, chronic myelomonocytic leukemia; AML, acute myeloid leukemia; CML, chronic myeloid leukemia; MCL, mast cell leukemia; CNL, chronic neutrophilic leukemia; NBM, normal BM; and nt, not tested.